Milan, Italy – 9 October, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™ (EU) / SOFTAG™ (U.S.) bioresorbable scaffolds for breast ...
Advanced biomaterial device designed for use in lumpectomy surgeries Interim results from the first 25 of 94 patients at 6 ...
Has more than 30 years of experience bringing innovations to market, including one of the world’s first drug-eluting coronary stents at Angiotech Pharma Appointment adds world-class capabilities to ...
Milan, Italy - January 8, 2026 - Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™/SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue ...
The MarketWatch News Department was not involved in the creation of this content. -- Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing ...
Tensive S.r.l. raised €14 million (US$14.5 million) in a series A financing round for its bio-absorbable breast implant Regenera, for patients undergoing reconstructive surgery after lumpectomy. The ...
24-month Phase I follow-up data show positive outcomes are maintained High levels of investigator and patient satisfaction, excellent safety profile Ongoing registrational trial will yield top-line ...
Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits of device Primary safety and secondary performance objectives met ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results